The cell surface-associated glycopeptides and extracellular signals derived from the proteolytic processing of MUC1 on the cancer cells alter the cytotoxicity and migration of natural killer (NK) cells and T-cells by modulating NK group 2D (NKG2D) ligands and β-catenin, respectively [74,152,153]. The gene discussed is MUC1; the disease is cancer.